Category: EQS Newswire

EQS-News / 01/06/2022 / 11:46 UTC+8 Pacific Green Appoints the Principal Contractor and Operations & Maintenance Provider for its Richborough Energy Park Battery Storage System in the UK DOVER, DE / ACCESSWIRE / May 31, 2022 / Pacific Green Technologies, Inc. (the "Company" or "Pacific Green", (OTCQB:PGTK)) announces that it has entered into an agreement with Instalcom Limited ("Instalcom") to be the principal contractor (the "Principal Contractor Agreement") for its 99.98 MW battery energy storage system ("BESS") in development at Richborough Energy Park in Kent, England. The award of this Principal Contractor Agreement, in conjunction with the battery supply agreement previously signed with Shanghai Election Gotion New Energy Technology Co., Ltd., paves the way for construction to begin in early July 2022. Scott Poulter, Pacific Green's Chief Executive, commented: "Instalcom has a 30 year track-record of delivering complex, large-scale energy infrastructure projects throughout the UK. We're very pleased to have found such a partner with their capabilities, dedication and the resources to support Pacific Green as we rapidly scale up our battery energy park developments in the UK to 1.1 GW and beyond." As well as the Principal Contractor Agreement, Pacific Green has also awarded Instalcom with an operations and maintenance contract (the "Operations & Maintenance Agreement") to provide comprehensive operations and maintenance services for Pacific Green's Richborough Energy Park. The Operations & Maintenance Agreement will begin at the start of Richborough Energy Park's commercial operations via the UK's National Grid in June 2023. Vince Bowler, Instalcom's Managing Director, remarked: "Instalcom is very excited to be supporting Pacific Green in the development and delivery of this low carbon technology project that will make a positive contribution to the UK's Build Back Greener Net Zero Strategy." Scott added: "This is another huge milestone in Pacific Green's corporate growth into one of the world's leading vertical energy developers. Our UK pipeline utilizes Pacific Green's proprietary "ODCO2 Energy Development Platform" to deliver end to end capital efficient renewable energy and storage parks to the market." About Pacific Green Technologies, Inc.: Pacific Green Technologies, Inc. is focused on addressing the world's need for cleaner and more sustainable energy. The Company offers BESS, Concentrated Solar Power (CSP) and Photovoltaic (PV) energy solutions to complement its marine environmental technologies and emissions control divisions. For more information, visit Pacific Green's website:www.pacificgreentechnologies.com About Instalcom Limited: Instalcom is a Utility Contractor operating in the power, water, telecoms, rail and oil & gas sectors. Instalcom is owned by OCU Group Limited, who operate with a work force in excess of 2,000 personnel and annual revenues exceeding £210 million (US$264 million). Notice Regarding Forward-Looking Statements: This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the construction of the 99.98 MW BESS the Company is to develop in Kent, the continuation of the Principal Contractor Agreement and the continuation of the Operations & Maintenance Agreement; and any potential business developments in the UK and future interest in the Company's battery, solar and emissions control technologies. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic and political conditions, the continuation of the Principal Contractor Agreement and the continuation of the Operations & Maintenance Agreement, and the ongoing impact of the COVID-19 pandemic. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although the Company believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in the Company's annual report on Form 10-K for the most recent fiscal year, the Company's quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. Contact: Scott Poulter, Chairman & CEOPacific Green TechnologiesT: +1 (302) 601-4659 SOURCE: Pacific Green Technologies, Inc. File: Pacific Green Appoints the Principal Contractor and Operations & Maintenance Provider for its Richborough Energy Park Battery Storage System in the UK 01/06/2022 Dissemination of a Financial Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS-News / 31/05/2022 / 04:34 EST/EDT Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna Moderna to become marketing authorization holder in Japan and be responsible for all import, local regulatory, development, quality assurance, and commercial activities for SpikevaxTM from August 1, 2022 Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period CAMBRIDGE, Mass. and OSAKA, Japan – May 31, 2022-- Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda (TSE:4502)(NYSE:TAK) have announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine SpikevaxTM (mRNA-1273) from Takeda to Moderna in Japan as of August 1, 2022. Moderna will assume responsibility for all Spikevax™ activities, including import, local regulatory, development, quality assurance, and commercialization. Takeda will continue to provide distribution support under the current national vaccination campaign for Moderna COVID-19 vaccines for a transitional period. Both companies will be responsible for ensuring proper implementation of operations associated with this transfer. “We thank Takeda for their support and partnership in bringing our COVID-19 vaccine to Japan over the last two years, and for helping to play a key role in addressing the pandemic across the country,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “We are happy to take this important step as we continue to build and strengthen our own commercial organization in Japan, and we look forward to continuing our partnership with Takeda in 2022.” “We are proud to have been able to support the early public health response to the COVID-19 pandemic by using the Takeda network to provide Moderna’s COVID-19 vaccine to the people of Japan,” said Gary Dubin, M.D., President, Global Vaccine Business Unit at Takeda. “Following transfer of the marketing authorization to Moderna, we will continue to provide transitional distribution support to ensure supply continuity." Authorized Use Moderna's COVID-19 vaccine SpikevaxTM has been granted authorization for special approval by the Ministry of Health, Labour and Welfare of Japan. In Japan, it is indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2. A dose may be given to people aged 12 years or older. A second dose should be given as soon as possible if more than four weeks have passed since the first vaccination. A booster dose may be given at least five months after the second dose for people aged 18 years and older. A fourth dose may be given at least five months after the third dose for the elderly etc. considering the benefits and risks. About Moderna In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both ground-breaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use and approval of one of the earliest and most-effective vaccines against the COVID-19 pandemic. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com. Takeda’s Commitment to Vaccines Vaccines prevent 2 to 3 million deaths each year and have transformed global public health. For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19, Zika and norovirus. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development and manufacturing to advance a pipeline of vaccines to address some of the world’s most pressing public health needs. For more information, visit www.TakedaVaccines.com. About Takeda Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com. Moderna Forward Looking Statements This post contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the transfer of marketing authorization holder from Takeda to Moderna in Japan for the Spikevax COVID-19 vaccine (mRNA-1273) and the responsibilities undertaken by each company in association with the transfer. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include those other risks and uncertainties described under the heading “Risk Factors” in Moderna’s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this post in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date hereof. Takeda Important Notice For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. Takeda Forward-Looking Statements This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results. Medical informationThis press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Moderna Contacts: Media: Luke Mircea Willats Director, Corporate Communications Luke.Mirceawillats@modernatx.com Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations 617-209-5834 Lavina.Talukdar@modernatx.com Takeda Contacts Media Mika Shirai mika.shirai@takeda.com+81332782407 SOURCE: Moderna, Inc. File: Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna 31/05/2022 Dissemination of a Marketing Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS-News / 30/05/2022 / 09:57 UTC+8 Huobi Tech 2022 Interim Results: Steady and Orderly Development with the Principle of Diversification and Compliance Financial Highlights ● The total revenue amounted to approximately HK$351.8 million, representing an increase of approximately34.4% or HK$90.1 million; ● The total assets reached to approximately HK$1.34 billion, representing an increase of 87.4%; The Group maintained an abundant capital with the cash and cash equivalents of HK$374.6 million; ● The revenue of virtual asset ecosystem business reached HK$96.8 million, accounting for 27.5% of the total revenue (the businesses have officially launched since last April), which was a testament to the effectiveness of Huobi Tech’s development strategy; ● The revenue of blockchain ecosystem business reached anticipated level with revenue of HK$44.5 million; providing momentum for the total revenue growth; ● The revenue of power-related & electrical/electronic products business amounted to HK$210.4 million, representing an increase of approximately 30.9%, which kept strengthening the Group’s overall revenue resilience; ● In order to build a leading one-stop compliant virtual asset service platform, the Group has allocated more resources and cost input, which resulted in a remarkable progress in virtual asset ecosystem business and a further strengthening of the sustainable ecosystem. [27 May 2022, Hong Kong] Huobi Technology Holdings Limited (“Huobi Tech”, stock code: 1611.HK) and together with its subsidiaries (the “Group”) is pleased to announce its interim results for the six months ended 31 March 2022 (“the Reporting Period”). Despite the complexity of the international market during the period, the Group achieved a steady and orderly development of its performance and successful implementation of its multiple business, through timely strategic adjustments and rational allocation of resources. At the same time, the Group increased its input in new business lines, strengthened the sustainable ecosystem of its overall business, and brought about further optimisation of the revenue structure. This is highly consistent with the strategic direction of the Group and is a testament to the effectiveness of its development strategy. The Group recorded a total revenue of approximately HK$351.8 million for the six months ended 31 March 2022, representing an increase of approximately 34.4% compared with the same period of last year. The gross profit of the Group was HK$101.2 million during the Reporting Period, representing a decrease of approximately 24.5%. A loss of HK$48.8 million was recorded. This is due to the increase in costs associated with the launch and layout of new businesses and the application for compliance licenses in key global markets during the Reporting Period compared with the same period last year. Meanwhile, with the steady growth of the Group’s business and the smooth rollout of new compliant business, the total assets reached to HK$1.34 billion, a year-on-year increase of 87.4%. Besides, the Group maintained an abundant capital with the cash and cash equivalents of HK$374.6 million during the Reporting Period. Steady and Orderly Development with the Principle of Diversification and Compliance During the Reporting Period, the Group benefited from its development principle of “Diversification, Compliance and Professionalism” and achieved sound business operation. The revenue from the manufacturing business increased by 30.9% year-on-year to 210.4 million during the Reporting Period, thanks to the recovery of the global market from the epidemic in the second half of 2021, which strengthened the Group’s overall revenue resilience. At the same time, the Group continued to focus on the development of the blockchain ecosystem and achieved the anticipated level of revenue from the business, providing momentum to the total revenue growth. The technology solutions business, which provide data centre and cloud-based services to global customers in the innovative technology sectors, generated a revenue of HK$38.7 million; SaaS, which provide maintaining, supporting, developing and implementing customizations for virtual asset trading platform clients, generated a revenue of HK$5.9 million. It is worth mentioning that the Group fully leveraged its compliance advantages and allocated more resources and cost input to adapt itself into the wave of global digital economy. By strengthening the sustainable ecosystem consisting of emerging compliant business, the Group achieved a stable start in its virtual asset ecosystem business with revenue reaching the expected level of HK$96.8 million. Since the official launch in April 2021, the proportion of the revenue from virtual asset ecosystem has achieved 27.5% as of the reporting date, reflecting the effectiveness of the Group’s development strategy. Actively Pursuing Layout on Forward-Looking Business to Strengthen the Sustainable Ecosystem Consisting of Emerging Business The rapid development of blockchain technologies have prompted global regulations and supervision to achieve leapfrog development. Increased regulatory awareness and improved regulatory landscape have made “Compliance & Security” an important prerequisite for riding the wave of digital assets. To this end, as the first listed company in Asia dedicated to building a one-stop compliant virtual asset service platform, Huobi Tech actively built an ecosystem moating around its mission of “Developing Diversely with Compliance as Primary” to provide a compliant, secure and professional high-quality channel for institutions and individuals to enter the virtual asset world. The Group has made remarkable progress in its business through proactive market insight and strategic layouts. Huobi Asset Management (Hong Kong) Limited (“Huobi Asset Management”), one of the subsidiaries of the Group, which holds Type 4 (Advising on Securities) and Type 9 (Asset Management) licenses issued by the Securities and Futures Commission of Hong Kong (“Hong Kong SFC”), has launched innovative compliant fund products to meet the diverse market demands since April 2021, and continued to meet the market demands to launch various products, above which creating favorable conditions for the ecosystem. Huobi Trust Company Limited (“Huobi Trust HK”) which holds the Hong Kong Trust or Company Service Provider (TCSP) license, and Huobi Trust Company (“Huobi Trust US”) which holds the Retail Trust Company License (Nevada USA), have both gained recognition from customers for their leading technologies and professional services since the official launch in May 2021. In addition, the Group kept capturing the market dynamics in a real-time manner, and successfully developed new compliant business for institutions and individuals, including over-the-counter (OTC) brokerage and asset-backed lending service during the Reporting Period. With the service system and quality improved in a short term, both business achieved rapid revenue growth, further consolidating the Group’s core competitiveness. Meanwhile, in response to the market trend, Huobi Tech Capital, the Group's strategic investment and M&A unit, was officially established after this Report Period (in April). In the future, Huobi Tech Capital will grasp the trend of the digital era and conduct in-depth research on Web3.0, DeFi, NFT and Metaverse to provide momentum for the Group to become a leading one-stop compliant virtual asset service platform. With a vision of “Based in Hong Kong with a Global Perspective”, the Group has been actively cooperating with global regulators to make the industry more compliant and mainstream. During the Reporting Period, the Group joined hands with leading companies in the industry to launch the “Crypto Market Integrity Coalition (CMIC)” to support the cultivation of a fair digital asset marketplace and enhance the confidence of global regulators. In addition, the Group is actively applying for the Type 1 and Type 7 regulated activities licenses under the Securities and Futures Ordinance to be issued by Hong Kong SFC, with a view to conducting as a compliant virtual asset trading platform in Hong Kong, and jointly explore the future of compliance with regulatory authorities. In Singapore, the Group has submitted the application to Monetary Authority of Singapore (“MAS”) for a digital asset activities license, aiming to conduct the regulated operation of the local exchange and expand the scope of business for the Group. Looking forward, Huobi Tech will actively embrace the opportunities of the age and uphold the mission of “Diversification, Compliance and Professionalism” to establish a strategic fulcrum for the sustainable development of virtual assets, thus leading traditional financial institutions into the virtual asset world with self-built “One-stop Compliant Virtual Asset Service Platform”. The Group believes that we will create stable and long-term values for our shareholders as long as we insist a global strategic mindset and leverage the first-mover advantage of compliance. - End - About Huobi Tech Holdings Limited Huobi Technology Holdings Limited (“Huobi Tech”, Stock Code: 1611.HK) was listed on the Main Board of the Stock Exchange of Hong Kong Limited in November 2016. Actively developing the blockchain ecosystem and virtual asset ecosystem, Huobi Tech is committed to becoming the leading one-stop compliant virtual asset service platform. Huobi Tech currently offers data centre services, cloud-based services, SaaS, virtual asset management, trust & custody, OTC brokerage, lending, trading platform, strategic investment and M&A, and other related services. At the same time, Huobi Tech is applying for virtual asset and finance-related licenses in major markets around the world. Up to now, Huobi Tech’s subsidiaries have successfully obtained the approval to conduct Type 4 (Advising on Securities) and Type 9 (Asset Management) regulated activities from the Securities and Futures Commission of Hong Kong, registered as a Trust Company in Hong Kong with the Trust or Company Service Provider License (Hong Kong) and the Retail Trust Company License (Nevada USA). File: Huobi Tech 2022 Interim Results: Steady and Orderly Development with the Principle of Diversification and Compliance 30/05/2022 Dissemination of a Financial Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS-News / 30/05/2022 / 09:00 UTC+8 CMMB acquires 51% equity interest in fast-growing Hong Kong based AI company IITH, creating significant synergy effect and fueling the long-term stable development of the Group Asia's largest high-orbit satellite based mobile data connectivity and transmission service provider – CMMB Vision Holdings Limited (471), is pleased to announce that CMMB recently entered into the Agreement with Chi Capital Holdings Ltd, the Controlling Shareholder of the Company for the acquisition of 51% interest in International IT Hub Limited (IITH) at the consideration of HK$1.00. Upon completion of acquisition, IITH will become an indirect wholly-owned subsidiary of the Company, and its results, assets and liabilities will be consolidated into the accounts of the Group. IITH is a Hong Kong based Artificial Intelligence (AI) and big-data Internet-of-things (IoT) hardware and software solutions provider with operations in Hong Kong and China. It has advanced competence in areas such as AI-based video analytics, facial recognition and license plate recognition as well as IoT solutions. IITH was established in 2018 in Hong Kong and has built a solid and extensive client base covering various industries, such as government bodies, NGOs, consumer and service sectors in Hong Kong and China. IITH leverages its self-developed algorithm with AI & IOT solution to enhance operating efficiency to facilitate client’s specific need. The management team of IITH includes members who have AI and IOT related field’s experience for over 15 years. In 2021, IITH has recorded revenue of over HK$10.7 million. Due to the expected increasing investment in digital transformation from government and enterprise, the management of IITH expects to generate at least HK$30 million in revenue for the next two years. The Company believes the acquisition of IITH should create new revenue stream with enormous future prospect to the Group. On one hand, IITH will leverage CMMB platform to carry on and expand its AI / IoT business as an independent subsidiary. On the other hand, IITH will provide its AI and big-data analytics competence to bolster Company’s satellite-5G converged data-as-a-service infrastructure into a vertically integrated operating platform with data aggregation, distribution, analytics so as to maximize business opportunities. Upgrade and expand Company’s PCB Electronics Components business with new AI and IoT based hardware/software solutions The Company has recognised the trend of AI and IoT technologies playing in the new-generation digital electronic devices, robotics, and appliances, etc. IITH provides advanced hardware and software solutions and robotic products in areas of AI-based video analytics, facial recognition, vehicle recognition, logistics, and community management, which can be highly complementary to the Company’s PCB electronic component business platform as a whole. The Acquisition is expected to add AI and IoT based hardware and software product with higher profit margin flows to the Company and improve the profitability of the PCB electronic component business. Bolster Company’s satellite-5G converged data-as-a-service infrastructure with AI and big-data competence One of the core businesses the Company is expanding from of its CMMB multimedia technology is to provide data-as-a-service with a holistic satellite-5G converged mobile delivery and consumption infrastructure, which could be used to provide digital infotainment and data analytics for smart-car and smart city use. The Company’s future satellite capabilities will include remote sensing for collecting and transmitting earth observation data such as carbon emission, climate change, and energy for industry and government use. The addition of IITH will embolden the Company’s satellite-5G platform with AI and big-data capabilities to perform a variety of data analytics and embolden the Company to be a comprehensive data-as-a-service operator. According to the above favourable reasons, CMMB believes the Acquisition is a most efficient and cost-effective way for the Company to enter into the AI & IoT market and acquire the advanced competence, which will accelerate the development of the satellite-5G converged data-as-a-service infrastructure of the Company, further capture the huge potential of satellite internet market in APAC region. File: CMMB acquires 51% equity interest in fast-growing Hong Kong based AI company IITH, creating significant synergy effect and fueling the long-term stable development of the Group 30/05/2022 Dissemination of a Financial Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS-News / 27/05/2022 / 12:05 UTC+8 CN Logistics International Holdings Limited 嘉泓物流國際控股有限公司 (Incorporated in the Cayman Islands with limited liability)(Stock Code: 2130) CN Logistics Annual General Meeting Held Successfully Outstanding Achievements Prove Management Team’s Extraordinary Strength [Hong Kong – 27 May 2022] A well-established international logistics solutions provider, CN Logistics International Holdings Limited (the “Company”, together with its subsidiaries, the “Group”, stock code: 2130) has successfully held its annual general meeting today and voted on a series of agenda. Over the past year, the Group has achieved breakthroughs in various areas thanks to the endless efforts of the Board of Directors and staff. Leveraging on the capital strength accumulated after its listing on the main board of Hong Kong, the Group is able to rapidly expand its business scale by acquiring wholly-owned subsidiaries in Italy and Switzerland, as well as a service provider operating in cruise logistics, bringing the brand awareness of CN Logistics to a new high. To support the surging customer demand, the Group has strengthened its global layout by setting up branches in Malaysia, Thailand, Vietnam and more countries, and closely worked with strategic partners to consolidate its global air freight and logistics network. To grasp the opportunities that arise with eCommerce development, the Group launched its fine wine eCommerce platform “PJF Wines” (PJFWines.com) last year to target the huge consumer market in PRC. Earlier this year, the Group released another eCommerce platform “CNShip4Shop” (CNShipforShop.com) to provide one-stop international groupage solutions to end customers in 12 Asian regions, riding on our international footprint and background in serving brand customers. The new eCommerce platforms will be new growth engines and create more value for the Group. Mr. Lau Shek Yau, Chairman and Non-Executive Director of CN Logistics, said: “In the past year, CN Logistics has lived up to the expectations of our shareholders and continued to work for their best interests. As one of the fastest-growing logistics companies in Hong Kong, we always embrace innovation and entrepreneurial spirits. While consolidating our presence in existing markets, we are also devoted to diversifying our revenue channels, striving to become at the forefront of the industry. Take sustainable development as an example, we are one of the pioneers in the logistic industry to provide one-stop green logistics solutions to customers, and the integrated solutions are highly recognised by our brand customers. To reduce carbon emissions generated from daily operations, we have been working closely with our customers to promote waste reduction and energy conservation, several electric vehicles have also been introduced recently to further promote the development of green transportation. All in all, we are committed and will continue to develop CN Logistics into a high-quality company that leads the market and rewards its shareholders.” - End - About CN Logistics International Holdings Limited Established in 1991, CN Logistics is a well-established international logistics solutions provider with a core business of providing air freight forwarding services and distribution and logistics services in relation to fashion products and fine wine, primarily focusing on high-end fashion (including luxury and affordable luxury) products. According to the CIC Report, in 2019, the Company ranked first in the distribution and logistics market for high-end fashion products in both the PRC and Hong Kong. This press release is issued by DLK Advisory Limited on behalf of CN Logistics International Holdings Limited. For enquiries, please contact: DLK Advisory 金通策略 Telephone: 28577101 Email: pr@dlkadvisory.com File: CN Logistics Annual General Meeting Held Successfully Outstanding Achievements Prove Management Team’s Extraordinary Strength 27/05/2022 Dissemination of a Financial Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS-News / 27/05/2022 / 10:00 UTC+8 SEAPRWire and EQS via SeaPRwire.com Enter into a Partnership in Media Cooperation Singapore - SEAPRWire and EQS via SeaPRwire.com announce a media partnership in Asia (East and Southeast Asia). The partnership includes media list expansion and media outreaching business cooperation. The partnership covers mainland China, Hong Kong, Singapore, Thailand, Vietnam, Malaysia, Indonesia, and the Philippines. Both parties look forward to further cooperation in the future. About EQS via SeaPRwire.com EQS via SeaPRwire.com is a leading international cloud provider in the fields of corporate compliance, investor relations and sustainability reporting (ESG tech). Working with EQS via SeaPRwire.com, thousands of companies worldwide inspire trust by fulfilling complex regulatory requirements in a reliable and secure manner, minimizing risks and communicating their business success and its impact on society and the climate transparently to stakeholders. For more information about EQS: www.eqs.com About SEAPRWire SEAPRWire (https://www.seaprwire.com/) is a market-moving financial and business news source in Southeast Asia, trusted by institutional investors and fintech platforms in Asia to identify trading and investing opportunities and build investor experiences. It has a strong media network in Southeast Asia, indexing news from thousands of worldwide sources. SEAPRWire's media network support multi-lingual press release distribution, including English, Chinese, Vietnamese, Thai, Malay, Indonesian, Filipino and more. For more information, please email cs@seaprwire.com or https://newsroom.seaprwire.com/. File: SEAPRWire and EQS via SeaPRwire.com Enter into a Partnership in Media Cooperation 27/05/2022 Dissemination of a Marketing Press Release, transmitted by EQS via SeaPRwire.com.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com